Most Read Articles
6 days ago
The risk of developing myopic macular degeneration (MMD) is high among older individuals, women, those with lower education, greater myopia severity, and longer axial length, according to data from a consortium of Asian studies. Furthermore, myopic spherical equivalent is the strongest single predictor of MMD.
Jairia Dela Cruz, 2 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
6 days ago
A novel diagnostic tool, called the Pneumonia Lung Ultrasound Score (PLUS), is an easy, biomarker-derived, and accurate method for detecting acute pneumonia in the very old, a recent study has found.
11 Sep 2020
Men who use calcium channel blockers (CCBs) are at risk of developing prostate cancer, and the risk increases with the duration of CCB exposure, according to the results of a systematic review and meta-analysis.

Product Highlight - Calubia

01 Sep 2020

A Call to Take Action

  • Treatment of advanced prostate cancer (in combination with an LHRH analogue therapy or surgical castration)1
  • Treatment of locally advanced prostate cancer at high risk for disease progression (as adjuvant to radical prostatectomy or radiotherapy)1
  • Affordable price at (Php 4,670.40/box)
  • Better tolerability profile2
  • Lower incidence of treatment withdrawal2
  • Superior agent compared to flutamide and nilutamide in combined androgen blockade3,4


References:
1) Full product information of Calubia.
2) Schellhammer PF, Sharifi R, Block NL et al. Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostate carcinoma: final results of a multicentre, double-blind, randomized trial. British Journal of Urology 1997; 80:278.
3) Klotz L, Schellhammer P.CAB: the case of bicalutamide. Clin Prostate Cancer 2005; 3: 215-219.
4) Akaza H, Hinotsu S, Usami M, Arai Y, Kanetake H, Naito S et al. Study Group for the CAB Therapy of Prostate Cancer. CAB with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer 2009; 115: 3437-3445.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Philippines digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
The risk of developing myopic macular degeneration (MMD) is high among older individuals, women, those with lower education, greater myopia severity, and longer axial length, according to data from a consortium of Asian studies. Furthermore, myopic spherical equivalent is the strongest single predictor of MMD.
Jairia Dela Cruz, 2 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
6 days ago
A novel diagnostic tool, called the Pneumonia Lung Ultrasound Score (PLUS), is an easy, biomarker-derived, and accurate method for detecting acute pneumonia in the very old, a recent study has found.
11 Sep 2020
Men who use calcium channel blockers (CCBs) are at risk of developing prostate cancer, and the risk increases with the duration of CCB exposure, according to the results of a systematic review and meta-analysis.